Hamburg - Delayed Quote EUR
BioNTech SE (22UA.HM)
92.50
+2.55
+(2.83%)
At close: May 2 at 5:25:12 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
207,700
207,700
5,371,400
13,577,400
889,700
Investing Cash Flow
-2,081,200
-2,081,200
-6,954,500
-35,300
-566,100
Financing Cash Flow
-45,900
-45,900
-778,600
-1,419,300
94,200
End Cash Position
9,761,900
9,761,900
11,663,700
13,875,100
1,692,700
Capital Expenditure
-452,300
-452,300
-705,500
-363,300
-154,000
Issuance of Capital Stock
--
--
--
110,500
160,900
Issuance of Debt
--
--
300
800
--
Repayment of Debt
-45,900
-45,900
-40,400
-59,900
-66,700
Repurchase of Capital Stock
--
--
-738,500
-986,400
--
Free Cash Flow
-244,600
-244,600
4,665,900
13,214,100
735,700
12/31/2021 - 10/18/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0QF.HA Moderna Inc
24.22
-0.64%
0QF.BE Moderna Inc
24.28
-3.21%
0QF.MU Moderna, Inc.
24.21
-0.23%
1ZL.SG Zai Lab Ltd
27.40
-1.44%
0OT.DU Ocular Therapeutix Inc
7.67
+4.78%
VX1.HA Vertex Pharmaceuticals Inc
439.60
-0.92%
VX1.DU Vertex Pharmaceuticals Inc
440.35
-0.94%
VX1.MU Vertex Pharmaceuticals Inc
439.25
-0.82%
HTD.SG Corcept Therapeutics Inc
64.08
+1.65%
1T3.BE Syndax Pharmaceuticals Inc
12.00
-4.00%